Cargando…
Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
BACKGROUND: Urothelial bladder cancer is the ninth most common cancer. Despite surgical and chemotherapeutic treatment the prognosis is still poor once bladder cancer progresses to a muscle-invasive state. Discovery of new diagnostic markers and pathophysiologic effectors might help to contribute to...
Autores principales: | Niedworok, Christian, Röck, Katharina, Kretschmer, Inga, Freudenberger, Till, Nagy, Nadine, Szarvas, Tibor, vom Dorp, Frank, Reis, Henning, Rübben, Herbert, Fischer, Jens W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819308/ https://www.ncbi.nlm.nih.gov/pubmed/24223213 http://dx.doi.org/10.1371/journal.pone.0080084 |
Ejemplares similares
-
The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
por: Niedworok, Christian, et al.
Publicado: (2013) -
The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness
por: Pinto, Filipe, et al.
Publicado: (2021) -
The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
por: Bowe, Mark A., et al.
Publicado: (2000) -
Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases
por: Halari, Chidambra D., et al.
Publicado: (2021) -
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)